ConductScience.org, home

Gene · 9211

NIH grants526

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleLGI1 papersNewest fiscal year
R01NS126227Seronegative Autoimmune Encephalopathies: Biomarker Discovery, Validation & Deep Phenotyping92025
UL1TR001863Yale Clinical and Translational Science Award72025
P01AG026276Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study32025
P30AG066444Alzheimer's Disease Research Center32025
R01NS029709Excitability and Plasticity of Developing Epileptic Brain32025
P01AI073693Anti-NMDA Receptor Antibodies in Adult Brain Dysfunction: Lessons from Lupus22025
P30AG062677Mayo Alzheimer's Disease Research Center22025
P30CA008748Cancer Center Support Grant22025
P30CA016056Roswell Park Cancer Center Support Grant22025
P30CA034196Cancer Center Support (CORE) Grant22025
P50HD103538Intellectual and Developmental Disabilities Research Centers22025
T32NS061779Neurologic Clinical Epidemiology Training Program22025
U01NS120885KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions22025
U19AG032438Bridge Funding for Dominantly Inherited Alzheimer Network22025
U24AG021886National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)22025
UL1TR002345Washington University Institute of Clinical and Translational Sciences22025
UL1TR002377Mayo Clinic Center for Clinical and Translational Science (CCaTS)22025
ZIADE000704Clinical and Mechanistic Investigations of Salivary Gland Dysfunction22025
F31NS134125Role of TRIM46 in neuronal polarity in vivo12025
F31NS139435Molecular mechanisms of Kv1 channel localization at the axon initial segment12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/9211/grants